Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

To Bridge Health Disparities, Diagnose Lupus Early & Improve Access

  |  Issue: March 2019  |  

Susan Bernstein is a freelance medical journalist based in Atlanta.

References

  1. U.S. Department of Health and Human Services. The Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020. Phase I report: Recommendations for the framework and format of Healthy People 2020.
  2. Gross D, Caron A, Blanco I, et al. Lupus Education Advancement Project (LEAP): Rheumatology fellows serving as educators increased knowledge and efficiency in lupus recognition and referral by providers in primary and emergency care. Arthritis Rheumatol. 2016;68(suppl 10).
  3. Monrad SU, Zeller JL, Craig CL, Diponio LA. Musculoskeletal education in U.S. medical schools: Lessons from the past and suggestions for the future. Curr Rev Musculoskelet Med. 2011 Sep;4(3):91–98.
  4. Battafarano DF, Ditmyer M, Bolster MB, et al. 2015 American College of Rheumatology Workforce Study: Supply and demand projections of adult rheumatology workforce, 2015–2030. Arthritis Care Res (Hoboken). 2018 Apr;70(4):617–626.

Related Articles
    G-Stock Studio / shutterstock.com

    Conquering Systemic Racism in Medicine

    2020 has not only borne witness to a global pandemic, but also to increasing fervor in the fight for racial equity. In a wave of opposition to the systemic racism in the U.S., people have been in the streets demonstrating and protesting against social injustice and have taken to social media to promote political action….

    Racial Disparities in Rheumatology: What Are We Doing About It?

    The data tell the story. Despite improvements in overall outcomes for common rheumatologic conditions, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), white patients fare better than minority patients, and sometimes substantially better. Even with new biologic therapies that have significantly altered the course of disease for patients with RA, outcomes for minorities…